Machine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study

被引:5
|
作者
Kim, Rachel S. [1 ]
Simon, Steven [2 ]
Powers, Brett [1 ]
Sandhu, Amneet [3 ]
Sanchez, Jose [3 ]
Borne, Ryan T. [3 ]
Tumolo, Alexis [3 ]
Zipse, Matthew [3 ]
West, J. Jason [3 ]
Aleong, Ryan [3 ]
Tzou, Wendy [3 ]
Rosenberg, Michael A. [1 ,3 ]
机构
[1] Univ Colorado, Colorado Ctr Personalized Med, Sch Med, Aurora, CO 80045 USA
[2] Univ Colorado, Div Cardiol, Sch Med, Aurora, CO 80045 USA
[3] Univ Colorado, Div Cardiol, Clin Cardiac Electrophysiol Sect, Sch Med, 12631 East 17th Ave,Mail Stop B130, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
atrial fibrillation; rhythm-control; machine learning; ablation; antiarrhythmia agents; data science; biostatistics; artificial intelligence; CATHETER ABLATION; ANTIARRHYTHMIC-DRUGS; STROKE PREVENTION; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULANTS; RANDOMIZED-TRIAL; WARFARIN; ASPIRIN; RISK; METAANALYSIS;
D O I
10.2196/29225
中图分类号
R-058 [];
学科分类号
摘要
Background: The identification of an appropriate rhythm management strategy for patients diagnosed with atrial fibrillation (AF) remains a major challenge for providers. Although clinical trials have identified subgroups of patients in whom a rate- or rhythm-control strategy might be indicated to improve outcomes, the wide range of presentations and risk factors among patients presenting with AF makes such approaches challenging. The strength of electronic health records is the ability to build in logic to guide management decisions, such that the system can automatically identify patients in whom a rhythm-control strategy is more likely and can promote efficient referrals to specialists. However, like any clinical decision support tool, there is a balance between interpretability and accurate prediction. Objective: This study aims to create an electronic health record-based prediction tool to guide patient referral to specialists for rhythm-control management by comparing different machine learning algorithms. Methods: We compared machine learning models of increasing complexity and used up to 50,845 variables to predict the rhythm-control strategy in 42,022 patients within the University of Colorado Health system at the time of AF diagnosis. Models were evaluated on the basis of their classification accuracy, defined by the F1 score and other metrics, and interpretability, captured Results: We found that age was by far the strongest single predictor of a rhythm-control strategy but that greater accuracy could be achieved with more complex models incorporating neural networks and more predictors for each participant. We determined that the impact of better prediction models was notable primarily in the rate of inappropriate referrals for rhythm-control, in which more complex models provided an average of 20% fewer inappropriate referrals than simpler, more interpretable models. Conclusions: We conclude that any health care system seeking to incorporate algorithms to guide rhythm management for patients with AF will need to address this trade-off between prediction accuracy and model interpretability.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Rhythm and rate control of atrial fibrillation in the emergency department - A large community-based observational study
    Gilbert, Cameron J.
    Angaran, Paul
    Mariano, Zana
    Aves, Theresa
    Dorian, Paul
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2018, 20 (06) : 834 - 840
  • [42] Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study
    Li, Zhi-Zhao
    Du, Xin
    Guo, Xue-yuan
    Tang, Ri-bo
    Jiang, Chao
    Liu, Nian
    Chang, San-shuai
    Yu, Rong-hui
    Long, De-yong
    Bai, Rong
    Sang, Cai-hua
    Li, Song-nan
    Dong, Jian-zeng
    Ma, Chang-sheng
    MEDICAL SCIENCE MONITOR, 2018, 24 : 3903 - 3908
  • [43] Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study
    Zhong, Xia
    Jiao, Huachen
    Zhao, Dongsheng
    Teng, Jing
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [44] Rate and Rhythm Control Treatment in the Elderly and Very Elderly Patients With Atrial Fibrillation: An Observational Cohort Study of 1497 Patients
    Klamer, Thomas A.
    Bots, Sophie H.
    Neefs, Jolien
    Tulevski, Igor I.
    den Ruijter, Hester M.
    Somsen, G. Aernout
    de Groot, Joris R.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (10)
  • [45] Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Rancomized Study (the RAFAS Trial)
    Park, Junbeom
    Shim, Jaemin
    Lee, Jung Myung
    Park, Jin-Kyu
    Heo, JoonNyung
    Chang, Yoonkyung
    Song, Tae-Jin
    Kim, Dong-Hyeok
    Lee, Hye Ah
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Young Dae
    Nam, Hyo Suk
    Joung, Boyoung
    Lee, Moon-Hyoung
    Heo, Ji Hoe
    Pak, Hui-Nam
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (03):
  • [46] Rhythm-control therapy for new-onset atrial fibrillation in critically ill patients: A post hoc analysis from the prospective multicenter observational AFTER-ICU study
    Yoshida, Takuo
    Uchino, Shigehiko
    Sasabuchi, Yusuke
    Kyo, Michihito
    Igarashi, Takashi
    Inoue, Haruka
    IJC HEART & VASCULATURE, 2021, 33
  • [47] Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study
    Diemberger, Igor
    Spadotto, Alberto
    Massaro, Giulia
    Amadori, Martina
    Damaschin, Liviu
    Martignani, Cristian
    Ziacchi, Matteo
    Biffi, Mauro
    Galie, Nazzareno
    Boriani, Giuseppe
    BIOLOGY-BASEL, 2023, 12 (01):
  • [48] Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial
    Jensen, Maerit
    Suling, Anna
    Metzner, Andreas
    Schnabel, Renate B.
    Borof, Katrin
    Goette, Andreas
    Haeusler, Karl Georg
    Zapf, Antonia
    Wegscheider, Karl
    Fabritz, Larissa
    Diener, Hans-Christoph
    Thomalla, Gotz
    Kirchhof, Paulus
    LANCET NEUROLOGY, 2023, 22 (01) : 45 - 54
  • [49] Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case-control study
    Zhong, Xia
    Yu, Jie
    Zhao, Dongsheng
    Teng, Jing
    Jiao, Huachen
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [50] Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study
    Zanella, Luca
    Zoppellaro, Giacomo
    Marigo, Lucia
    Denas, Gentian
    Padayattil Jose, Seena
    Pengo, Vittorio
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (05)